This web site is part of the Business Intelligence Division of Informa PLC
Roche Holding AG
Drug Names(s): R1440
Description: R1440 is an oral glucokinase activator (GKA), which is designed to rapidly lower blood glucose levels by increasing glucose uptake in the liver and increasing insulin secretion from the pancreas.
Additional information available to subscribers only: